Search

everythinglearnresearchcommunity

for

Search:↓

Millets may help reduce chemotherapy side effects like nausea, fatigue, and hair loss.

Metformin might help treat certain skin conditions, but more research is needed.

Dermal Papilla cells are a promising tool for evaluating hair growth treatments.

PGD2 increases androgen receptor activity in hair cells, which could be targeted to treat hair loss.

Sebaceous glands can heal and regenerate after injury using their own stem cells and help from hair follicle cells.

The circadian clock affects skin stem cell behavior, impacting aging and cancer risk.

Testosterone therapy aims to treat hormone deficiencies and various conditions safely and effectively, but requires careful patient monitoring due to potential side effects.

The revised study on how inflammation affects cancer stem cells was accepted after improving clarity and structure.

The revised manuscript on how inflammation affects cancer stem cells was accepted after addressing issues with clarity and detail.

The reviewers found the manuscript on inflammation's role in cancer stem cells to be relevant but suggested it needs clarity, more background information, discussion on immune cells' role in tumors, updated references, and grammar corrections.

The reviewers suggest clarifying the abstract, adding background on inflammation's effect on stem cells and cancer, discussing immune cells' role in tumors, and considering inflammation's potential to reduce cancer growth.

The reviewers suggest major revisions for clarity and inclusion of recent findings on inflammation's role in cancer.

Reviewers suggest clarifying the abstract, adding background on inflammation's effect on cancer, discussing immune cell roles, including counter studies, and correcting grammar.

The reviewers suggest clarifying and expanding on the role of inflammation in stem cell-related cancer development.

ALA-PDT is effective and safe for chronic X-ray dermatitis, providing complete or partial remission.

The vitamin D receptor is crucial for bone health and affects various body systems, with mutations potentially leading to disease.

Prolactin may play a significant role in skin and hair health and could be a target for treating skin and hair disorders.

Actinic keratosis can lead to skin cancer, is more common in fair-skinned people, and can be reduced with sunscreen and treated effectively.

Hair follicle bulge cells don't help skin regrow after glucocorticoid damage; interfollicular epidermis cells do.

The document concludes that stem cell inactivity is actively controlled and important for tissue repair and balance.

Meis1 is crucial for skin health and tumor development.

Blocking Rab27a slows hair growth, while blocking Rab27b encourages it.

Nanoparticles show promise for better wound healing, but more research is needed to ensure safety and effectiveness.

Lipocalin-Type Prostaglandin D2 Synthase (L-PGDS) is a protein that plays many roles in the body, including sleep regulation, pain management, food intake, and protection against harmful substances. It also affects fat metabolism, glucose intolerance, cell maturation, and is involved in various diseases like diabetes, cancer, and arthritis. It can influence sex organ development and embryonic cell differentiation, and its levels can be used as a diagnostic marker for certain conditions.

Understanding how EDC genes are regulated can help develop better drugs for skin diseases.

Retinoids can prevent skin cancer in high-risk people but have side effects and require more research on dosing and effectiveness.

Finasteride and minoxidil are effective for hair regrowth, while treatments for alopecia areata have varying success and continuous treatment is necessary.

Testosterone may have a dual role in COVID-19, potentially worsening outcomes in men, and testosterone therapy could help some patients, but more research is needed.

Trichoepitheliomas can be hard to distinguish from other skin conditions and often start in teenage years.

Bexxar is highly effective as a first treatment for non-Hodgkin's lymphoma, with most patients alive and many in remission after eight years.